An Unusual Presentation of Neurosarcoidosis

27 September 2022 : Case report USA

Challenging differential diagnosis, Rare disease

Erdal Sarac^12ABCDE, Sergul A. Erzurum^13ABCDEF, Ali Arif^1CDEF*

DOI: 10.12659/AJCR.937125

Am J Case Rep 2022; 23:e937125

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 2. Table of comparative frequency of clinical neurological manifestations in neurosarcoidosis.

Neurological features	Frequency	Prognosis*
Neurological features	Frequency	Acute	Chornic
Cranial neuropathy	50–70%	Good	Good
Parenchymal brain lesions	50%	Fair	Poor
Cognitive/behavioral manifestations	20%	Good	Fair
Mentingeal disease	10–20%	Good	Poor
Peripheral neuropathy	15%	Fair	Fair
Seizures	5–10%	Good	Good
Spinal lesions	5–10%	Good	Fair
Myopathy	1.4–2.3%	Fair	Poor
^* Acute is defined as 3 months. ^** If there is active brain inflammation seizures may be refractory; if the inflammatory process can be controlled seizures usually respond to standard anti-seizure meditory process can be controlled seizures usually respond to standard anti-seizure medications.

Back to the Article